H Ekimoto

1.7k total citations
47 papers, 1.4k citations indexed

About

H Ekimoto is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H Ekimoto has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H Ekimoto's work include Cancer therapeutics and mechanisms (13 papers), Phytochemical compounds biological activities (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). H Ekimoto is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Phytochemical compounds biological activities (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). H Ekimoto collaborates with scholars based in Japan and Pakistan. H Ekimoto's co-authors include Teruo Okano, Kazunori Kataoka, M. Yokoyama, Yoshinori Sakurai, Tohru Kikuchi, Shigetoshi Kadota, Lamek Marpaung, Katsutoshi Takahashi, Makoto Ojika and Kiyoyuki Yamada and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Controlled Release and British Journal of Cancer.

In The Last Decade

H Ekimoto

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Ekimoto Japan 19 759 380 314 196 125 47 1.4k
Michael C. Bibby United Kingdom 20 778 1.0× 291 0.8× 142 0.5× 389 2.0× 111 0.9× 47 1.7k
Paola Milla Italy 21 870 1.1× 149 0.4× 287 0.9× 213 1.1× 80 0.6× 60 1.7k
Heinz H. Fiebig Germany 27 845 1.1× 513 1.4× 348 1.1× 526 2.7× 319 2.6× 69 2.0k
Govindarajan Manikumar United States 21 1.2k 1.5× 418 1.1× 130 0.4× 492 2.5× 201 1.6× 39 1.6k
Mehdi Rajabi United States 21 960 1.3× 420 1.1× 205 0.7× 263 1.3× 139 1.1× 54 1.9k
Janique Dewelle Belgium 15 590 0.8× 288 0.8× 158 0.5× 171 0.9× 82 0.7× 18 1.1k
Ping Cai China 21 530 0.7× 210 0.6× 360 1.1× 168 0.9× 184 1.5× 59 1.4k
Chong Ock Lee South Korea 21 773 1.0× 310 0.8× 85 0.3× 303 1.5× 92 0.7× 53 1.3k
Yongseok Choi South Korea 23 964 1.3× 397 1.0× 227 0.7× 100 0.5× 68 0.5× 68 1.6k
Giuseppe Cassinelli Italy 23 863 1.1× 542 1.4× 70 0.2× 396 2.0× 335 2.7× 48 1.7k

Countries citing papers authored by H Ekimoto

Since Specialization
Citations

This map shows the geographic impact of H Ekimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Ekimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Ekimoto more than expected).

Fields of papers citing papers by H Ekimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Ekimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Ekimoto. The network helps show where H Ekimoto may publish in the future.

Co-authorship network of co-authors of H Ekimoto

This figure shows the co-authorship network connecting the top 25 collaborators of H Ekimoto. A scholar is included among the top collaborators of H Ekimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Ekimoto. H Ekimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuse, Takeshi, S Teramoto, Eiichi Sudo, et al.. (1999). ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury. European Respiratory Journal. 13(1). 71–77. 24 indexed citations
2.
Takatsuki, Satoshi, et al.. (1996). Studies on Cytotoxic Activity of Animal and Plant Crude Drugs. 50(2). 145–157. 5 indexed citations
3.
Igarashi, Kazuei, Kaori Koga, Yuqi He, et al.. (1995). Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.. PubMed. 55(12). 2615–9. 27 indexed citations
4.
Okada, M., Seishi Kudo, Osamu Miyazaki, et al.. (1995). Antitumoral efficacy and pharmacokinetic properties of pirarubicin upon hepatic intra-arterial injection in the rabbit V x 2 tumour model. British Journal of Cancer. 71(3). 518–524. 23 indexed citations
5.
Sato, Akira, et al.. (1995). Characteristic antitumor activity of cytarabine ocfosfate against human colorectal adenocarcinoma xenografts in nude mice. Cancer Chemotherapy and Pharmacology. 36(6). 459–462. 5 indexed citations
6.
Kanbe, T, et al.. (1994). Phenotypic Reversion Induced by Anthracyclines in ras Oncogene-Expressed Cells; Structure-Activity Relationships.. Biological and Pharmaceutical Bulletin. 17(4). 527–530. 1 indexed citations
7.
Hori, Makoto, et al.. (1992). Synergism between 5-fluorouracil and oxanosine in inhibiting growth of ras-expressed cells in vitro and in vivo.. The Journal of Antibiotics. 45(2). 283–285. 1 indexed citations
8.
Sasaki, Hiroshi, Kimihiko Takada, Yoshiteru Terashima, et al.. (1991). Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and l-phenylalanine mustard are sensitive to Δ7-prostaglandin Δ1 and Δ12-prostaglandin J2. Gynecologic Oncology. 41(1). 36–40. 26 indexed citations
9.
Sugawara, Isamu, Kazuya Okamoto, Yoshikazu Sugimoto, et al.. (1991). Characterization of an Etoposide‐resistant Human K562 Cell Line, K/eto. Japanese Journal of Cancer Research. 82(9). 1035–1043. 12 indexed citations
10.
11.
12.
Kusama, Kaoru, H Ekimoto, Takahiro Ishii, Keigo Okamoto, & Ken Takahashi. (1991). [Antitumor activity by long-term administration of low-dose etoposide].. PubMed. 18(6). 959–63. 2 indexed citations
13.
14.
Kadota, Shigetoshi, Lamek Marpaung, Tohru Kikuchi, & H Ekimoto. (1989). Antagonists of platelet activating factor from (L.) JACQ. Tetrahedron Letters. 30(9). 1111–1114. 14 indexed citations
15.
Kadota, Shigetoshi, Lamek Marpaung, Tohru Kikuchi, & H Ekimoto. (1989). Mahonin and secomahoganin, new tetranortriterpenoids from Swietenia mahogani (L.) JACQ.. Chemical and Pharmaceutical Bulletin. 37(5). 1419–1421. 5 indexed citations
16.
Kuroda, Yasuo, et al.. (1989). Synthesis and antitumor activities of alkyl-1,4-butanediamine Pt(II) complexes having seven-membered ring structure.. Chemical and Pharmaceutical Bulletin. 37(9). 2406–2409. 15 indexed citations
17.
Takahashi, Katsutoshi, H Ekimoto, Kiyohiro Nishikawa, et al.. (1987). Liblomycin, a new analogue of bleomycin. Cancer Treatment Reviews. 14(3-4). 169–177. 16 indexed citations
18.
Ekimoto, H, et al.. (1984). Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice.. The Journal of Antibiotics. 37(6). 659–663. 10 indexed citations
19.
Ekimoto, H, HIROSHI KURAMOCHI, Katsutoshi Takahashi, Akira Matsuda, & HAMAO UMEZAWA. (1980). Kinetics of the reaction of bleomycin-Fe(II)-O2 complex with DNA.. The Journal of Antibiotics. 33(4). 426–434. 32 indexed citations
20.
Hamana, Masatomo, Hiroshi Noda, & H Ekimoto. (1976). Hydroxyalkylation of N-Alkoxyquinaldinium and -lepidinium Perchlorates. Heterocycles. 5(1). 339–339. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael C. Bibby Breakdown of academic impact, for papers by Paola Milla Breakdown of academic impact, for papers by Heinz H. Fiebig Breakdown of academic impact, for papers by Govindarajan Manikumar Breakdown of academic impact, for papers by Mehdi Rajabi Breakdown of academic impact, for papers by Janique Dewelle Breakdown of academic impact, for papers by Ping Cai Breakdown of academic impact, for papers by Chong Ock Lee Breakdown of academic impact, for papers by Yongseok Choi Breakdown of academic impact, for papers by Giuseppe Cassinelli
Rankless by CCL
2026